| Product NDC: | 0135-0461 |
| Proprietary Name: | ALLI |
| Non Proprietary Name: | orlistat |
| Active Ingredient(s): | 60 mg/1 & nbsp; orlistat |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0135-0461 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA021887 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070207 |
| Package NDC: | 0135-0461-03 |
| Package Description: | 120 CAPSULE in 1 BOTTLE (0135-0461-03) |
| NDC Code | 0135-0461-03 |
| Proprietary Name | ALLI |
| Package Description | 120 CAPSULE in 1 BOTTLE (0135-0461-03) |
| Product NDC | 0135-0461 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | orlistat |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070207 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | ORLISTAT |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |